


The Fund aims to achieve long term capital growth.
| Name | % Net Assets | 
|---|---|
| Care UK | 3.3% | 
| Dechra Pharmaceuticals | 3.1% | 
| RM | 3.1% | 
| Ultra Electronics Holdings | 2.9% | 
| Fisher (James) & Sons | 2.4% | 
| Chemring Group | 2.4% | 
| BPP Holdings | 2.3% | 
| Synergy Health | 2.2% | 
| Dignity | 2.2% | 
| Protherics | 2.2% | 
| Key | % Net Assets | 
|---|---|
| 3.3% | |
| 3.1% | |
| 3.1% | |
| 2.9% | |
| 87.6% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 25/01/1992 | 
|---|---|
| Fund Manager | Ed Robinson | 
| TER | 1.59 (30-Apr-2009) | 
| Minimum Investment | |
|---|---|
| Initial | 3000 | 
| Additional | 1,000 | 
| Savings | 100 | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.21 | 
You are here: research